<!DOCTYPE html>
<!-- paulirish.com/2008/conditional-stylesheets-vs-css-hacks-answer-neither/
-->
<!--[if lt IE 7]>
<html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en">
<![endif]-->
<!--[if IE 7]>
<html class="no-js lt-ie9 lt-ie8" lang="en">
<![endif]-->
<!--[if IE 8]>
<html class="no-js lt-ie9" lang="en">
<![endif]-->
<!--[if gt IE 8]>
<!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<head>
    <meta charset="utf-8" />
    <!-- Set the viewport width to device width for mobile -->
    <meta name="viewport" content="width=device-width" />
    <title>
        PracticeUpdate : Expert Opinion Item
    </title>
    <link rel="stylesheet" href="assets/css/app.css">
    <link rel="stylesheet" href="assets/css/font-awesome.css">
    <link rel="stylesheet" href="assets/css/fc-webicons.css">
    <link rel="stylesheet" href="assets/css/foundation-icons-general.css">
    <script src="assets/js/foundation/modernizr.foundation.js">
    </script>
    <!-- IE Fix for HTML5 Tags -->
    <!--[if lt IE 9]>
        <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js">
        </script>
    <![endif]-->
</head>

<body id="page" class="update off-canvas slide-nav expert-opinion-item logged-out">
    <div class="widget ad">
        <div id="leaderboard" class="Breast ad-container">
            <div class="ad-title">
                <span class="ad-title-text">
                    advertisement
                </span>
            </div>
            <!--/.ad-title-->
            <div id="leaderboardcontent" class="ad-content">
            </div>
            <!--.ad-content-->
        </div>
        <!--/#leaderboard.ad-container-->
    </div>
    <!--/.widget.ad-->
    <div class="page-header">
    </div>
    <!--/.page-header-->
    <div class="page-content">
        <section role="main">
            <div class="single-item-container">
                <article class="type-expert-opinion single-item">
                    <!-- info taken from: http://oncologystat.com/viewpoints/seminal_articles/Seminal_Articles_Germ_Cell_Tumors.html
                    -->
                    <div class="item-header-container">
                        <header class="item-header">
                            <div class="flag-container">
                                <span class="flag featured">
                                    <i class="icon-bolt">
                                    </i>
                                    featured
                                </span>
                                <span class="flag story-of-the-week">
                                    <i class="icon-bolt">
                                    </i>
                                    story of the week
                                </span>
                            </div>
                            <div class="meta pub-meta">
                                <span class="item-type">
                                    Seminal Article
                                </span>
                                <span class="item-pub-date">
                                    <time datetime="12-12-19">
                                        December 19, 2012
                                </span>
                            </div>
                            <hgroup class="item-title-container">
                                <h1 class="item-title">
                                    Seminal Articles—Head and Neck Cancer
                                </h1>
                                <p class="item-citation">
                                    <!-- {{source.citation}} -->
                                    2012 Nov 7, Ezra Cohen, MD
                                </p>
                            </hgroup>
                            <!-- /.item-title-container -->
                        </header>
                    </div>
                    <!--/.item-header-container-->
                    <div class="item-content-container">
                        <div class="item-content">
                            <div class="item-content-section">
                                <section class="seminal-article-body">
                                    <div class="seminal-article-body-container">
                                        <div class="source-container">
                                            <div class="vcard">
                                            </div>
                                            <!--/.vcard-->
                                        </div>
                                        <!--/.source-container-->
                                        <p>Based on our expert's review, here are the must-read articles for every oncologist about patients with head and neck cancer.</p><p><strong>Nasopharyngeal Locally Advanced Cancer</strong></p><p>1. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. <a target="_blank" href="http://ac.els-cdn.com/S0360301605022212/1-s2.0-S0360301605022212-main.pdf?_tid=5aa21078-1f81-11e2-8468-00000aacb35e&amp;acdnat=1351265300_17685e9fc0aedadf2997e83c5682099b">Int J Radiat Oncol Biol Phys. 2006;64(1):47-56</a>.</p><p>2. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. <a target="_blank" href="http://jco.ascopubs.org/content/16/4/1310.abstract">J Clin Oncol. 1998;16(4):1310-1317</a>.</p><p>3. Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S1470204511703205">Lancet Oncol. 2012;13(2):163-171</a>.</p><p><strong>Squamous Cell Carcinoma Adjuvant Therapy</strong></p><p>4. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa053422">N Engl J Med. 2006;354(6):567-578</a>. <strong>Free</strong></p><p>5. Bourhis J, Calais G, Lapeyre M, et al. Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0093775404003999">Semin Oncol. 2004;31(6):822-826</a>.</p><p>6. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. <a target="_blank" href="http://jnci.oxfordjournals.org/content/91/24/2081.full.pdf+html">J Natl Cancer Inst. 1999;91(24):2081-2086</a>. <strong>Free</strong></p><p>7. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJM199806183382503">N Engl J Med. 1998;338(25):1798-1804</a>. <strong>Free</strong></p><p>8. Cooper JS, Pajak TF, Forastiere AA, et al. Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa032646">N Engl J Med. 2004;350(19):1937-1944</a>. <strong>Free</strong></p><p>9. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/hed.20279/pdf">Head Neck. 2005;27(10):843-850</a>. <strong>Free</strong></p><p><strong>Induction Chemotherapy</strong></p><p>10. Lorch JH, Goloubeva O, Haddad RI, et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S1470204510702795">Lancet Oncol. 2011;12(2):153-159</a>.</p><p>11. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa070956">N Engl J Med. 2007;357(17):1705-1715</a>. <strong>Free</strong></p><p>12. Adelstein DJ, Moon J, Hanna E, et al. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216). <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967367/">Head Neck. 2010;32(2):221-228</a>. <strong>Free</strong></p><p>13. Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa071028">N Engl J Med. 2007;357(17):1695-1704</a>. <strong>Free</strong></p><p><strong>Organ Preservation for Locally Advanced Head and Neck Cancer</strong></p><p>14. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJM199106133242402">N Engl J Med. 1991;324(24):1685-1690</a>. <strong>Free</strong></p><p>15. Lefebvre JL, Andry G, Chevalier D, et al. Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. <a target="_blank" href="http://annonc.oxfordjournals.org/content/23/10/2708.long">Ann Oncol. 2012;23(10):2708-2714</a>.</p><p>16. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa031317">N Engl J Med. 2003;349(22):2091-2098</a>. <strong>Free</strong></p><p>17. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724854/">J Natl Cancer Inst. 2009;101(3):142-152</a>. <strong>Free</strong></p><p><strong>Locally Advanced/Unresectable and Metastatic Therapy</strong></p><p>18. Forastiere AA, Leong T, Rowinsky E, et al. Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. <a target="_blank" href="http://jco.ascopubs.org/content/19/4/1088.long">J Clin Oncol. 2001;19(4):1088-1095</a>.</p><p>19. Jacobs C, Lyman G, Velez-García E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. <a target="_blank" href="http://jco.ascopubs.org/content/10/2/257.abstract">J Clin Oncol. 1992;10(2):257-263</a>.</p><p>20. Burtness B, Goldwasser MA, Flood W, et al. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. <a target="_blank" href="http://jco.ascopubs.org/content/23/34/8646.long">J Clin Oncol. 2005;23(34):8646-8654</a>.</p><p>21. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. <a target="_blank" href="http://jco.ascopubs.org/content/10/8/1245.abstract">J Clin Oncol. 1992;10(8):1245-1251</a>.</p><p>22. Rischin D, Peters LJ, O'Sullivan B, et al. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. <a target="_blank" href="http://jco.ascopubs.org/content/28/18/2989.long">J Clin Oncol. 2010;28(18):2989-2995</a>.</p><p>23. Bourhis J, Sire C, Graff P, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S1470204511703461">Lancet Oncol. 2012;13(2):145-153</a>.</p><p>24. Ghadjar P, Simcock M, Studer G, et al. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0360301610036953">Int J Radiat Oncol Biol Phys. 2012;82(2):524-531</a>.</p><p>25. Quon H, Leong T, Haselow R, et al. Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382). <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0360301610008898">Int J Radiat Oncol Biol Phys. 2011;81(3):719-725</a>.</p><p><strong>Recurrent/Metastatic Disease</strong></p><p>26. Tortochaux J, Tao Y, Tournay E, et al. Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0167814011003367">Radiother Oncol. 2011;100(1):70-75</a>.</p><p>27. Machiels JP, Subramanian S, Ruzsa A, et al. Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S1470204511700341">Lancet Oncol. 2011;12(4):333-343</a>.</p><p>28. Vermorken J, Stohlmacher J, Davidenko I, et al. Primary efficacy and safety results of SPECTRUM, a phase 3 trial in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without panitumumab. <a target="_blank" href="http://annonc.oxfordjournals.org/content/21/suppl_8/NP.full.pdf+html?sid=908fda0c-9175-4b6a-a5c1-a2a5fba30481">Ann Oncol. 2010;21(Suppl 8):viii1-12.LBA26</a>.</p><p>29. Urba S, van Herpen CM, Sahoo TP, et al. Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study. <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/cncr.27449/abstract;jsessionid=77D45BAD67A5BAD346D986C7439A5179.d02t03?systemMessage=Wiley+Online+Library+will+be+disrupted+on+27+October+from+10%3A00-12%3A00+BST+%2805%3A00-07%3A00+EDT%29+for+essential+maintenanc">Cancer. 2012;118(19):4694-4705</a>.</p><p>30. Gibson MK, Li Y, Murphy B, et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. <a target="_blank" href="http://jco.ascopubs.org/content/23/15/3562.full">J Clin Oncol. 2005;23(15):3562&ndash;3567</a>.</p><p>31. Stewart JS, Cohen EE, Licitra L, et al. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]. <a target="_blank" href="http://jco.ascopubs.org/content/27/11/1864.full?sid=64766f7d-b42d-49ba-9b45-2e41afe76032%3C/a%3E.%3C/p%3E%3Cp%3E%3Cstrong%3ESquamous%20Cell%20Carcinoma%20Prognosis%3C/strong%3E%3C/p%3E%3Cp%3E32.%20Posner%20MR,%20Lorch%20JH,%20Goloubeva%20O,%20et%20al.%20Survival%20and%20human%20papillomavirus%20in%20oropharynx%20cancer%20in%20TAX%20324:%20a%20subset%20analysis%20from%20an%20international%20phase%20III%20trial.%20%3Ca%20href=">Ann Oncol. 2011;22(5):1071-1077</a>. <strong>Free</strong></p><p>33. D'Souza G, Kreimer AR, Viscidi R, et al. Case&ndash;Control Study of Human Papillomavirus and Oropharyngeal Cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa065497">N Engl J Med.2007;356(19):1944-1956</a>. <strong>Free</strong></p><p>34. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. <a target="_blank" href="http://jnci.oxfordjournals.org/content/100/6/407.full.pdf+html">J Natl Cancer Inst. 2008;100(6):407-420</a>. <strong>Free</strong></p><p>35. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. <a target="_blank" href="http://jnci.oxfordjournals.org/content/100/4/261.full.pdf+html">J Natl Cancer Inst. 2008;100(4):261-269</a>. <strong>Free</strong></p><p><strong>Thyroid Cancer</strong></p><p>36. Wells SA, Robinson BG, Gagel RF, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. <a target="_blank" href="http://jco.ascopubs.org/content/30/2/134.abstract">J Clin Oncol. 2012;30(2):134-141</a>.</p><p>37. Cohen EEW, Rosen LS, Vokes EE, et al. Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study. <a target="_blank" href="http://jco.ascopubs.org/content/26/29/4708.full.pdf+html?sid=a4ac10dd-d2df-4618-9c57-bdb4d7676e15">J Clin Oncol. 2008:26(29)4708-4713</a>.</p><p>38. Bible KC, Suman VJ, Molina JR, et al. Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107731/">Lancet Oncol. 2010;11(10):962&ndash;972</a>. <strong>Free</strong></p><p>39. Sherman SI, Wirth LJ, Droz J-P, et al. Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa075853">N Engl J Med. 2008;359(1):31-42</a>. <strong>Free</strong></p><p></p>
                                    </div>
                                    <!--/.seminal-article-body-container -->
                                </section>
                                <!-- /.seminal-article-body -->
                            </div>
                            <!-- ./item-content-section -->
                        </div>
                        <!-- ./item-content -->
                    </div>
                    <!-- /.item-conten-container -->
                    <hr />
                    <footer class="copyright item-footer">
                        <img class="logo" src="content/img/feed/imng_logo.gif" alt="IMNG Medical Media"
                        />
                        <p>
                            Copyright &copy; 2012 Elsevier
                        </p>
                    </footer>
            </div>
            <!--/.item-container-->
            <div class="recommended">
                <div class="recent">
                </div>
                <!--/.recent-->
                <div class="ad">
                    <img src="http://placehold.it/300x250" align="ad" title="ad" />
                </div>
            </div>
            <!--/.recommended-->
        </section>
        <!--/[role="main"]-->
        <section id="sidebar" role="complementary">
            <div class="dashboard">
                <div class="panel cta register">
                    <p>
                        <!-- Meet Our Experts -->
                        Become a member to customize this page.
                        <p>
                            <a class="button" href="#action-register">Register for free</a>
                </div>
                <!--/.panel.cta.register-->
                <div class="component user-console">
                </div>
                <!--/.component.user-console-->
                <div class="component user-topic">
                </div>
                <!--/.component.user-topic-->
                <div class="component topic-spotlight">
                </div>
                <!--/.component.topic-spotlight-->
                <div class="panel">
                    <img src="http://placehold.it/200x200" />
                    <p>
                        <!-- Meet Our Experts -->
                        Meet our Advisory and Editorial Boards comprised of physician editors
                        and world-renowned experts.
                        <p>
                </div>
            </div>
            <!--/.sidebar-->
        </section>
        <!--/.[role="complimentary"]-->
    </div>
    <!--/.page-content-->
    <footer class="page-footer">
    </footer>
    <!-- /.page-footer -->
    <!-- Included JS Files (Uncompressed) -->
    <script src="assets/js/foundation/jquery.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.accordion.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.alerts.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.buttons.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.forms.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.mediaQueryToggle.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.navigation.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.orbit.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.reveal.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tabs.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tooltips.js">
    </script>
    <script src="assets/js/foundation/jquery.placeholder.js">
    </script>
    <script src="assets/js/foundation/app.js">
    </script>
    <script src="assets/js/foundation/jquery.offcanvas.js">
    </script>
    <script src="assets/js/mustache.js">
    </script>
    <!-- Mustache - homepage feed template -->
    <script>
                    	<!--
	Mustache - homepage feed template -->
	$.getJSON('content/json/feed.json', function(data) {
	    $.get('assets/mustache/feed-item.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.stream-container').html(html);
	    });

	});

	<!--
	Mustache - homepage recent template -->
	$.getJSON('content/json/recent.json', function(data) {
	    $.get('assets/mustache/recent.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.recent').html(html);
	    });

	});

	<!--
	Mustache - homepage user - console template -->
	$.getJSON('content/json/user-console.json', function(data) {
	    $.get('assets/mustache/user-console.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-console').html(html);
	    });
	});

	<!--
	Mustache - homepage user - topic template -->
	$.getJSON('content/json/user-topic.json', function(data) {
	    $.get('assets/mustache/user-topic.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-topic').html(html);
	    });
	});

	<!--
	Mustache - homepage topic - spotlight template -->
	$.getJSON('content/json/topic-spotlight.json', function(data) {
	    $.get('assets/mustache/topic-spotlight.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.topic-spotlight').html(html);
	    });
	});
</script>
</body>

</html>